Skip to main content
SpringerLink
Log in
Book cover

Diabetes Epidemiology, Genetics, Pathogenesis, Diagnosis, Prevention, and Treatment pp 641–653Cite as

Insulin Pumps

  • Reference work entry
  • First Online:

Part of the book series: Endocrinology ((ENDOCR))

Abstract

Insulin pump therapy (continuous subcutaneous insulin infusion, CSII) is a form of intensified insulin treatment involving subcutaneous infusion of short-acting insulin from a portable pump. There is a well-established evidence base for the effectiveness of CSII in type 1 diabetes, which includes reduction in HbA1c, blood glucose variability, and all grades of hypoglycemia compared to MDI, but more research is needed on how new long-acting insulin preparations and more effective diabetes education will reduce the number who do not achieve target levels of control on MDI and who are thus candidates for CSII. Insulin pump therapy is an affordable, cost-effective therapeutic option for most healthcare settings. There is an increasing role for CSII in patients with poorly controlled type 2 diabetes who are not adequately managed on MDI, but smaller, cheaper, and simpler “patch” pumps are likely to be needed to make insulin pump therapy cost-effective in this type of diabetes.

This is a preview of subscription content, log in via an institution.

References

  • Aberle I, Scholz U, Bach-Kliegel B, Fischer C, Gorny M, Langer K, Kliegel M. Psychological aspects in continuous subcutaneous insulin infusion: a retrospective study. J Psychol. 2009;14:147–60.

    Article  Google Scholar 

  • Bergenstal RM, Klonoff DC, Garg SK, Bode BW, Meredith M, Slover RH, Ahmann AJ, Welsh JB, Lee SW, Kaufman FR, ASPIRE In-Home Study Group. Threshold-based insulin-pump interruption for reduction of hypoglycemia. NEJM. 2013;369:224–32.

    Article  CAS  Google Scholar 

  • Choudhary P, Shin J, Wang Y, Evans ML, Hammond PJ, Kerr D, Shaw JA, Pickup JC, Amiel SA. Insulin pump therapy with automated insulin suspension in response to hypoglycemia: reduction in nocturnal hypoglycemia in those at greatest risk. Diabetes Care. 2011;34:2023–5.

    Article  CAS  Google Scholar 

  • Choudhary P, Ramasamy S, Green L, Gallen G, Pender S, Brackenridge A, Amiel SA, Pickup JC. Real-time continuous glucose monitoring reduces severe hypoglycemia in hypoglycemia-unaware patients with type 1 diabetes. Diabetes Care. 2013;36:4160–2.

    Article  CAS  Google Scholar 

  • Cobry E, McFann K, Messer L, Gage V, VanderWel B, Horton L, Chase PH. Timing of meal insulin boluses to achieve optimal postprandial glycemic control in patients with type 1 diabetes. Diabet Technol Ther. 2010;12:173–7.

    Article  CAS  Google Scholar 

  • de Vries L, Grushka Y, Lebenthal Y, Shalitin S, Phillip M. Factors associated with increased risk of insulin pump discontinuation in pediatric patients with type 1 diabetes. Pediatr Diabetes. 2011;12:506–12.

    Article  Google Scholar 

  • DeVries JH, Snoek FJ, Kostense PJ, Masurel N, Heine RJ. A randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy in type 1 diabetes for patients with long-standing poor glycemic control. Diabetes Care. 2002;25:2074–80.

    Article  CAS  Google Scholar 

  • Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. NEJM. 1993;329:977–86.

    Article  Google Scholar 

  • Edelman S, Bode BW, Bailey TS, Kipnes MS, Brunelle R, Chen X, Frias JP. Insulin pump therapy in patients with type 2 diabetes. Safely improved glycemic control using a simple insulin dosing regimen. Diabet Technol Ther. 2010;12:627–33.

    Article  CAS  Google Scholar 

  • Grunberger G, Abelseth J, Bailey T, Bode B, Handelsman Y, Hellman R, Jovanovič L, Lane W, Raskin P, Tamborlane W, Rothermel C. Consensus statement by the American Association of Clinical Endocrinologists/American College of Endocrinology Insulin Pump Management Task Force. Endocr Pract. 2014;20:463–89.

    Article  Google Scholar 

  • Jones SM, Quarry JL, Caldwell-McMillan M, Mauger DT, Gabbay RA. Optimal insulin pump dosing and postprandial glycemia following a pizza meal using the continuous glucose monitoring system. Diabet Technol Ther. 2005;7:233–40.

    Article  CAS  Google Scholar 

  • Koivisto VA, Yki-Järvinen H, Helve E, Pelkonen R. Pathogenesis and prevention of the dawn phenomenon in diabetic patients treated with CSII. Diabetes. 1986;35:78–82.

    Article  CAS  Google Scholar 

  • Kordonouri O, Hartmann R, Danne T. Treatment of type 1 diabetes in children and adolescents using modern insulin pumps. Diabetes Res Clin Pract. 2011;93(Suppl):S118–24.

    Article  CAS  Google Scholar 

  • Laimer M, Melmer A, Mader JK, Schütz-Fuhrmann I, Engels H-R, Götz G, Pfeifer M, Hermann JM, Stettler C, Holl RW. Variability of basal rate profiles in insulin pump therapy and association with complications in type 1 diabetes mellitus. PLoS One. 2016;11(3):e0150604. https://doi.org/10.1371/journal.pone.0150604.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lauritzen T, Pramming S, Deckert T, Binder C. Pharmacokinetics of continuous subcutaneous insulin infusion. Diabetologia. 1983;24:326–9.

    Article  CAS  Google Scholar 

  • Leinung M, Thompson S, Mingfrei Luo PA-C, Leykina L, Nardacci E. Use of insulin pump therapy in patients with type 2 diabetes after failure of multiple daily injections. Endocr Pract. 2013;19:9–13.

    Article  Google Scholar 

  • Ly TT, Nicholas JA, Retterath A, Lim EM, Davis EA, Jones TW. Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial. JAMA. 2013;310:1240–7.

    Article  CAS  Google Scholar 

  • McCoy RG, Van Houten HK, Ziegenfuss JY, Shah ND, Wermers RA, Smith SA. Increased mortality of patients with diabetes reporting severe hypoglycemia. Diabetes Care. 2012;35:1897–901.

    Article  Google Scholar 

  • Misso ML, Egberts KJ, Page M, O’Connor D, Shaw J. Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus. Cochrane Database Syst Rev. 2010;(1):Art. No.: CD005103. https://doi.org/10.1002/14651858.CD005103.pub2.

  • Morera J, Joubert M, Morello R, Rod A, Lireux B, Reznik Y. Sustained efficacy of insulin pump therapy in type 2 diabetes: 9-year follow-up in a cohort of 161 patients. Diabetes Care. 2016;39:e74–5.

    Article  CAS  Google Scholar 

  • Mukhopadhyay A, Fraser RB, Bolarinde O. Continuous subcutaneous insulin infusion vs. intensive conventional insulin therapy in pregnant diabetic women: a systematic review and meta-analysis of randomized, controlled trials. Am J Obstet Gynecol. 2007;197:447–56.

    Article  CAS  Google Scholar 

  • National Institute for Health and Care Excellence. Continuous subcutaneous insulin infusion for the treatment of diabetes mellitus. In: Technology appraisal guidance 151 (review of technology appraisal guidance 57). London, UK: NICE; 2008.

    Google Scholar 

  • Nixon R, Folwell R, Pickup JC. Variations in the quality and sustainability of long-term glycaemic control with continuous subcutaneous insulin infusion. Diabet Med. 2014;31:1174–7.

    Article  CAS  Google Scholar 

  • Olinder AL, Kernell A, Smide B. Missed bolus doses: devastating for metabolic control in CSII-treated adolescents with type 1 diabetes. Pediatr Diabetes. 2009;10:142–8.

    Article  CAS  Google Scholar 

  • Parkner T, Laursen T, Vestergaard ET, Hartvig H, Smedegaard JS, Lauritzen T, Christiansen JS. Insulin and glucose profiles during continuous subcutaneous insulin infusion compared with injection of a long-acting insulin in type 2 diabetes. Diabet Med. 2008;25:585–91.

    Article  CAS  Google Scholar 

  • Perkins BA, Ridell MC. Type 1 diabetes and exercise: using the insulin pump to maximum advantage. Can J Diabet. 2006;30:72–9.

    Article  CAS  Google Scholar 

  • Pickup JC. Insulin-pump therapy for type 1 diabetes mellitus. NEJM. 2012;366:1616–24.

    Article  CAS  Google Scholar 

  • Pickup JC, Sutton AJ. Severe hypoglycaemia and glycaemic control in type 1 diabetes: meta-analysis of multiple daily insulin injections versus continuous subcutaneous insulin infusion. Diabet Med. 2008;25:765–74.

    Article  CAS  Google Scholar 

  • Pickup JC, Keen H, Parsons JA, Alberti KGMM. Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemia. BMJ. 1978;i:204–7.

    Article  Google Scholar 

  • Pickup JC, Mattock MB, Kerry S. Glycaemic control with continuous subcutaneous insulin infusion compared to intensive insulin injection therapy in type 1 diabetes: meta-analysis of randomised controlled trials. BMJ. 2002;324:705–8.

    Article  CAS  Google Scholar 

  • Pickup JC, Kidd J, Burmiston S, Yemane N. Effectiveness of continuous subcutaneous insulin infusion in hypoglycaemia-prone type 1 diabetes: implications for NICE guidelines. Pract Diabet Int. 2005;22:10–4.

    Article  Google Scholar 

  • Pickup JC, Kidd J, Burmiston S, Yemane N. Determinants of glycaemic control in type 1 diabetes during intensified therapy with multiple daily insulin injections or continuous subcutaneous insulin infusion: importance of blood glucose variability. Diabet Metab Res Rev. 2006;22:232–7.

    Article  CAS  Google Scholar 

  • Pickup JC, Yemane N, Brackenridge A, Pender S. Nonmetabolic complications of continuous subcutaneous insulin infusion: a patient survey. Diabet Technol Ther. 2014;16:145–9.

    Article  CAS  Google Scholar 

  • Pozzilli P, Battelino T, Danne T, Hovorka R, Jarosz-Chobot P, Renard E. Continuous subcutaneous insulin infusion in diabetes: patient populations, safety, efficacy, and pharmacoeconomics. Diabetes Metab Res Rev. 2016;32:21–39.

    Article  CAS  Google Scholar 

  • Quirόs C, Giménez M, Ríos R, Careaga M, Roca D, Vidal M, Conget I. Long-term outcome of insulin pump therapy: reduction of hypoglycaemia and impact on glycaemic control. Diabet Med. 2016;33:1422. https://doi.org/10.1111/dme.13094.

    Article  CAS  Google Scholar 

  • Raskin P, Bode BW, Marks JB, Hirsch IB, Weinstein RL, McGill JB, Peterson GE, Mudaliar SR, Reinhardt RR. Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: a randomized, parallel-group, 24-week study. Diabetes Care. 2003;26:2598–603.

    Article  CAS  Google Scholar 

  • Retnakaran R, Hochman J, DeVries JH, Hanaire-Broutin H, Heine RJ, Melki V, Zinman B. Continuous subcutaneous insulin infusion versus multiple daily injections. The impact of baseline A1c. Diabetes Care. 2004;27:2590–6.

    Article  CAS  Google Scholar 

  • Reznik Y, Cohen O, Aronson R, Conget I, Runzis S, Castaneda J, Scott W Lee. Insulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes (OpT2mise): a randomised open-label controlled trial. The Lancet. 2014;384(9950):1265–1272.

    Article  CAS  Google Scholar 

  • Roze S, Smith-Palmer J, Valentine W, de Portu S, Nørgaard K, Pickup JC. Cost-effectiveness of continuous subcutaneous insulin infusion versus multiple daily injections of insulin in type 1 diabetes: a systematic review. Diabet Med. 2015;32:1415–24.

    Article  CAS  Google Scholar 

  • Sherr JL, Hermann JM, Campbell F, Foster NC, Hofer SE, Allgrove J, Maahs DM, Kapellen TM, Holman N, Tamborlane WV, Holl RW, Beck RW, Warner JT, T1D Exchange Clinic Network, DPV Initiative, National Paediatric Diabetes Audit, Royal College of Paediatrics and Child Health registries. Use of insulin pump therapy in children and adolescents with type 1 diabetes and its impact on metabolic control: comparison of results from three large, transatlantic paediatric registries. Diabetologia. 2016;59:87–91.

    Article  CAS  Google Scholar 

  • Steineck I, Cederholm J, Eliasson B, Rawshani A, Eeg-Olofsson K, Svensson A-M, Zethelius B, Avdic T, Landin-Olsson M, Jendle J, Gudbjörnsdóttir S, the Swedish National Diabetes Register. Insulin pump therapy, multiple daily injections, and cardiovascular mortality in 18,168 people with type 1 diabetes: observational study. BMJ. 2015;350:h3234.

    Article  Google Scholar 

  • Tamborlane WV, Sherwin RS, Genel M, Felig P. Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump. NEJM. 1979;300:573–8.

    Article  CAS  Google Scholar 

  • Wainstein J, Metzger M, Boaz M, Minuchin O, Cohen Y, Yaffe A, Yerushalmy Y, Raz I, Harman-Boehm I. Insulin pump therapy vs. multiple daily injections in obese type 2 diabetic patients. Diabet Med. 2005;22:1037–46.

    Article  CAS  Google Scholar 

  • Weissberg-Benchell J, Antisdel-Lomaglio J, Seshadri R. Insulin pump therapy. A meta-analysis. Diabetes Care. 2003;26:1079–87.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Diabetes and Nutritional Sciences, Faculty of Life Sciences and Medicine, King’s College London, Guy’s Hospital, London, UK

    John C. Pickup

Authors
  1. John C. Pickup
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to John C. Pickup .

Editor information

Editors and Affiliations

  1. Division of Endocrinology, Diabetes and Metabolism, University and Hospital Trust of Verona, Verona, Italy

    Enzo Bonora

  2. Diabetes Division, Diabetes Research Unit, University of Texas Health Science Center, San Antonio, TX, USA

    Ralph A. DeFronzo

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Pickup, J.C. (2018). Insulin Pumps. In: Bonora, E., DeFronzo, R. (eds) Diabetes Epidemiology, Genetics, Pathogenesis, Diagnosis, Prevention, and Treatment . Endocrinology. Springer, Cham. https://doi.org/10.1007/978-3-319-45015-5_22

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-45015-5_22

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-45014-8

  • Online ISBN: 978-3-319-45015-5

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation